SCHEMBL2854136

SCHEMBL2854136

Nc1nc(Sc2cccc(O)c2)nc(-c2cc(O)c(Cl)cc2Cl)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.41
NPC1 O15118 5/20 0.40
HTR2B P41595 1/20 0.38
PDE4D Q08499 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
CDK9 P50750 2/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
MTOR P42345 1/20 0.33
PIK3CG P48736 1/20 0.33
DHFR P00374 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2848078 0.80 LMNA (0.41) HSP90AA1SMN1; SMN2PIK3CDPIK3CAPIK3CG
SCHEMBL2847985 0.75 HSP90AA1 (0.50) HSP90AA1NPC1HTR2BPDE4DSMN1; SMN2
SCHEMBL4369252 0.73 HSP90AA1 (0.36) HSP90AA1NPC1HTR2BPDE4DSMN1; SMN2
SCHEMBL15101662 0.70 KDM4E (0.36) HSP90AA1NPC1SMN1; SMN2CDK9ALDH1A1
SCHEMBL5066591 0.66 NPC1 (0.62) HSP90AA1NPC1HTR2BPDE4DSMN1; SMN2
SCHEMBL4086685 0.66 HSP90AB1 (0.41) HSP90AA1HTR2BPDE4DADORA3ADORA2A
SCHEMBL4086644 0.65 HSP90AA1 (0.49) HSP90AA1NPC1HTR2BPDE4DSMN1; SMN2
SCHEMBL14071025 0.65 MAPK1 (0.46) HSP90AA1NPC1SMN1; SMN2ADORA3ALOX15
SCHEMBL4091505 0.63 HSP90AA1 (0.61) HSP90AA1HTR2BPDE4DPIK3CAMTOR
SCHEMBL13928104 0.63 HSP90AA1 (0.38) HSP90AA1NPC1HTR2BPDE4DSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362236-B2 Macrocyclic compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2013-01-29 US disclosed
US-8362236-B2 Macrocyclic compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2013-01-29 US disclosed
US-8362236-B2 Macrocyclic compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2013-01-29 US disclosed
EP-2119718-B1 MACROCYCLIC COMPOUND CHUGAI PHARMACEUTICAL CO LTD (JP) 2012-04-11 EP disclosed
EP-2119718-B1 MACROCYCLIC COMPOUND CHUGAI PHARMACEUTICAL CO LTD (JP) 2012-04-11 EP disclosed
US-20100056510-A1 Macrocyclic Compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-03-04 US disclosed
US-20100056510-A1 Macrocyclic Compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-03-04 US disclosed
US-20100056510-A1 Macrocyclic Compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-03-04 US disclosed
EP-2119718-A1 MACROCYCLIC COMPOUND Chugai Seiyaku Kabushiki Kaisha (JP) 2009-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056510-A1 Macrocyclic Compound HSP90AB1, HSP90B1, HSP90AA1 HSP90AA1 3/4885NPC1 1267/4885HTR2B 4374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.